DOGP · Dogecoin Cash, Inc.
$0.01
+0.00 (+1.41%)
At close · Sep 2
Going-concern doubt
— flagged Aug 19, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company has an accumulated deficit of $84,714,880 at June 30, 2026, which, among other factors, raises substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 19, 2026
Market Cap
$1.06M
Shares
162.61M
DOGP metrics
56 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$0.01
Market cap
$1.06M
Price action
19 metricsPrice change (1W)
-9.0%
Price change (30D)
+1.4%
Price change (3M)
-46.6%
Price change (6M)
-51.7%
Price change (YTD)
-58.5%
Price change (1Y)
-74.7%
Trailing year
Price change (5Y)
-98.2%
52-week high
$0.04
52-week low
$0.01
Change from 52-week high
-84.2%
Change from 52-week low
+7.6%
Annualized volatility
104.3%
Beta
-0.2
RSI (14D)
44.9
Price vs SMA 50
-7.6%
Price vs SMA 200
-49.9%
Avg volume (3M)
364,379
Relative volume
0.7
Average dollar volume
$3,062
Company
3 metricsSector
Healthcare
Industry
Health Information Services
Shares outstanding
162.61M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.5×
reciprocal yield 68.3%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-281.9%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
64.5%
Operating margin
-73.7%
Trailing 12 months
Net margin
-413.0%
Gross profit (TTM)
$465,499
Operating profit (TTM)
−$531,830
Net income (TTM)
−$2.98M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-13.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$721,379
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+16.6%
Year over year · more shares
Revenue CAGR (3Y)
-22.0%
Revenue CAGR (5Y)
-17.6%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
-137.4%
Debt / equity
—
Current ratio
1.0
EBITDA (TTM)
−$530,671
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
-5.4
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$10,971
Latest balance sheet
Cash & equivalents
$10,971
Total assets
$2.17M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$66,923
Capital expenditures (TTM)
$46,677
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
1
13F filer change QoQ
0
Institutional ownership
0.0%
Short interest
3 metricsShort interest
0.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
35 / 100
Insider activity
2 metricsNet insider buying (90D)
−$5,431
Insider-sentiment score
41 / 100
Risk flags
1 metricsGoing concern
Flagged